跳转至内容
Merck
所有图片(1)

主要文件

616454

Sigma-Aldrich

A 83-01

≥97% (HPLC), solid, TGF-β RI kinase inhibitor, Calbiochem

别名:

TGF-β RI 激酶抑制剂 IV

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C25H19N5S
分子量:
421.52
分類程式碼代碼:
12352200
NACRES:
NA.54

产品名称

TGF-β RI 激酶抑制剂 IV, TGF-β RI Kinase Inhibitor IV, CAS 909910-43-6, is a cell-permeable, selective inhibitor of ALK-4/5/7-mediated signaling (IC₅₀ = 45, 12, and 7.5 nM, respectively).

品質等級

化驗

≥97% (HPLC)

形狀

solid

製造商/商標名

Calbiochem®

儲存條件

OK to freeze
protect from light

顏色

pale yellow

溶解度

DMSO: 20 mg/mL

運輸包裝

ambient

儲存溫度

2-8°C

InChI

1S/C25H19N5S/c1-17-8-7-13-23(27-17)24-21(19-14-15-26-22-12-6-5-11-20(19)22)16-30(29-24)25(31)28-18-9-3-2-4-10-18/h2-16H,1H3,(H,28,31)

InChI 密鑰

HIJMSZGHKQPPJS-UHFFFAOYSA-N

一般說明

一种细胞渗透性三取代吡唑化合物,已显示在表达单个I型TGF-β受体的Mv1Lu R4-2转染子中选择性抑制ALK-4/5/7介导(荧光素酶转录活性测定中IC50分别为45、12和7.5 nM),但不抑制ALK-1/2/3/6介导的细胞信号。在浓度为1 µM的情况下,抑制HaCaT细胞中TGF-β-诱导的Smad2磷酸化和NMuMG细胞中的上皮间质转化。

生化/生理作用

主要靶标
ALK-4/5/7
产物不与ATP竞争。
可逆:否
细胞可渗透性:是
靶标IC50:抑制ALK-4/5/7介导的荧光素酶转录活性测定分别为45、12和7.5 nM

包裝

用惰性气体包装

警告

毒性:有害(C)

重構

复溶后,等分并冷冻保存(-20°C)。贮备溶液在-20°C下可稳定保存至多3个月。

其他說明

Tojo, M., et al. 2005.Cancer Sci.96, 791.

法律資訊

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Felix Kretzschmar et al.
Biology, 10(12) (2021-12-25)
As resident innate immune cells of the CNS, microglia play important essential roles during physiological and pathological situations. Recent reports have described the expression of Lilrb4 in disease-associated and aged microglia. Here, we characterized the expression of Lilrb4 in microglia
Alexander von Ehr et al.
Frontiers in cellular neuroscience, 14, 66-66 (2020-04-17)
Microglia are constantly surveying their microenvironment and rapidly react to impairments by changing their morphology, migrating toward stimuli and adopting gene expression profiles characterizing their activated state. The increased expression of the M2-like marker Mannose receptor 1 (Mrc1), which is
Erin R Spiller et al.
Frontiers in oncology, 11, 771173-771173 (2022-01-08)
Three-quarters of compounds that enter clinical trials fail to make it to market due to safety or efficacy concerns. This statistic strongly suggests a need for better screening methods that result in improved translatability of compounds during the preclinical testing
Abdelraheim Attaai et al.
Glia, 66(8), 1695-1708 (2018-03-27)
Microglia are involved in a widespread set of physiological and pathological processes and further play important roles during neurodevelopmental events. Postnatal maturation of microglia has been associated with the establishment of microglia-specific gene expression patterns. The mechanisms governing microglia maturation
Julian Heuberger et al.
EMBO molecular medicine, 13(4), e13191-e13191 (2021-02-06)
SARS-CoV-2, the agent that causes COVID-19, invades epithelial cells, including those of the respiratory and gastrointestinal mucosa, using angiotensin-converting enzyme-2 (ACE2) as a receptor. Subsequent inflammation can promote rapid virus clearance, but severe cases of COVID-19 are characterized by an

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门